| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |